Target
Programmed cell death 1 ligand 1
Ligand
BDBM649692
Substrate
n/a
Meas. Tech.
Affinity Test Between the Compounds of the Invention and hPD-L1 Protein
Kd
550±n/a nM
Citation
 XU, YZHANG, HZHU, QDU, HXIA, YYU, CHUANG, SLI, HZOU, Y NOVEL BIPHENYL DERIVATIVE AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF US Patent  US20240043392 Publication Date 2/8/2024 
Target
Name:
Programmed cell death 1 ligand 1
Synonyms:
B7 homolog 1 | B7-H1 | B7H1 | B7H1 | CD274 | CD_antigen=CD274 | PD-L1 | PD1L1_HUMAN | PDCD1 ligand 1 | PDCD1L1 | PDCD1LG1 | PDL1 | Programmed cell death 1 ligand 1 | Programmed death ligand 1
Type:
PROTEIN
Mol. Mass.:
33278.49
Organism:
Homo sapiens (Human)
Description:
ChEMBL_109807
Residue:
290
Sequence:
MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET
  
Inhibitor
Name:
BDBM649692
Synonyms:
(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3′-(3-(4-(((2-ethoxy-2-oxo ethyl)amino)methyl)-1H-1,2,3-triazol-1-yl)propoxy)-2,2′-dimethyl-[1,1′-biphenyl]-3-yl)methoxy) benzyl)glycine ethyl ester | US20240043392, Compound II-20
Type:
Small organic molecule
Emp. Form.:
C43H48ClN7O7
Mol. Mass.:
810.337
SMILES:
CCOC(=O)CNCc1cn(CCCOc2cccc(c2C)-c2cccc(COc3cc(OCc4cncc(c4)C#N)c(CNCC(=O)OCC)cc3Cl)c2C)nn1
Structure:
Search PDB for entries with ligand similarity: